Insider trading · Q3 2026 · CIK 805928

Axogen, Inc. (AXGN) insider trading.

In Q3 2026, insiders at Axogen, Inc. reported 6 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $4.7M.

Transactions
6
Purchases (P)
0
Sales (S)
4
Net shares, P minus S
-98,503
Insiders
4
Last filed
2026-09-04

Insiders

InsiderRelationshipTransactionsBuysSales
Wendell Amy McBrideDirector201
Began Marc AOfficer · EVP & General Counsel201
Tyndall Joseph A.Director101
Weiler Kathy JohnsonDirector101

Transactions

6 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-02Tyndall Joseph A.S (D)3,500$49.710,650Form 4
2026-08-11Wendell Amy McBrideM (A)13,353$14.85121,329Form 4
2026-08-11Wendell Amy McBrideS (D)13,353$48.42107,976Form 4
2026-08-10Began Marc AM (A)67,500$8.16117,635Form 4
2026-08-10Began Marc AS (D)67,500$47.3550,135Form 4
2026-08-07Weiler Kathy JohnsonS (D)14,150$45.30Form 4

Transaction codes in this quarter

Get AXGN insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=805928&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · AXGN company page · Axogen, Inc. on SEC.gov

Questions

Are insiders buying or selling Axogen, Inc. (AXGN)?

In Q3 2026, insiders at Axogen, Inc. reported 6 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $4.7M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Axogen, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/axgn.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.